During the past decade, Simonds-Sinon Regional Cancer Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 16 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Simonds-Sinon Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Eastern Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Simonds-Sinon Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Simonds-Sinon Regional Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Simonds-Sinon Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Simonds-Sinon Regional Cancer Center" are "Drug" (23 trials), "Other" (23 trials), "Biological" (13 trials), "Procedure" (8 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Nivolumab" (8 trials), "Docetaxel" (5 trials), "Quality-of-Life Assessment" (5 trials) and "Computed Tomography" (4 trials). Other intervention names were less common.

The vast majority of trials in "Simonds-Sinon Regional Cancer Center" are 25 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Simonds-Sinon Regional Cancer Center". undefined are not yet recruiting, 2 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Simonds-Sinon Regional Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Simonds-Sinon Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".